116 related articles for article (PubMed ID: 37160102)
1. A genetic portrait of metastatic seeds in lung adenocarcinoma.
Wu Q; Hu G
Cancer Cell; 2023 May; 41(5):828-830. PubMed ID: 37160102
[TBL] [Abstract][Full Text] [Related]
2. Genomic mapping of metastatic organotropism in lung adenocarcinoma.
Lengel HB; Mastrogiacomo B; Connolly JG; Tan KS; Liu Y; Fick CN; Dunne EG; He D; Lankadasari MB; Satravada BA; Sun Y; Kundra R; Fong C; Smith S; Riely GJ; Rudin CM; Gomez DR; Solit DB; Berger MF; Li BT; Mayo MW; Matei I; Lyden DC; Adusumilli PS; Schultz N; Sanchez-Vega F; Jones DR
Cancer Cell; 2023 May; 41(5):970-985.e3. PubMed ID: 37084736
[TBL] [Abstract][Full Text] [Related]
3. Genomic comparison between cerebrospinal fluid and primary tumor revealed the genetic events associated with brain metastasis in lung adenocarcinoma.
Deng Z; Cui L; Li P; Ren N; Zhong Z; Tang Z; Wang L; Gong J; Cheng H; Guan Y; Yi X; Xia X; Zhou R; He Z
Cell Death Dis; 2021 Oct; 12(10):935. PubMed ID: 34642306
[TBL] [Abstract][Full Text] [Related]
4. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
5. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study.
Shi J; Hua X; Zhu B; Ravichandran S; Wang M; Nguyen C; Brodie SA; Palleschi A; Alloisio M; Pariscenti G; Jones K; Zhou W; Bouk AJ; Boland J; Hicks B; Risch A; Bennett H; Luke BT; Song L; Duan J; Liu P; Kohno T; Chen Q; Meerzaman D; Marconett C; Laird-Offringa I; Mills I; Caporaso NE; Gail MH; Pesatori AC; Consonni D; Bertazzi PA; Chanock SJ; Landi MT
PLoS Med; 2016 Dec; 13(12):e1002162. PubMed ID: 27923066
[TBL] [Abstract][Full Text] [Related]
6. A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma.
Jones GD; Brandt WS; Shen R; Sanchez-Vega F; Tan KS; Martin A; Zhou J; Berger M; Solit DB; Schultz N; Rizvi H; Liu Y; Adamski A; Chaft JE; Riely GJ; Rocco G; Bott MJ; Molena D; Ladanyi M; Travis WD; Rekhtman N; Park BJ; Adusumilli PS; Lyden D; Imielinski M; Mayo MW; Li BT; Jones DR
JAMA Surg; 2021 Feb; 156(2):e205601. PubMed ID: 33355651
[TBL] [Abstract][Full Text] [Related]
7. Genomic landscape and evolution of arm aneuploidy in lung adenocarcinoma.
Gao B; Yang F; Han M; Bao H; Shen Y; Cao R; Wu X; Shao Y; Liu C; Zhang Z
Neoplasia; 2021 Sep; 23(9):870-878. PubMed ID: 34303217
[TBL] [Abstract][Full Text] [Related]
8. An individualized gene expression signature for prediction of lung adenocarcinoma metastases.
Qi L; Li T; Shi G; Wang J; Li X; Zhang S; Chen L; Qin Y; Gu Y; Zhao W; Guo Z
Mol Oncol; 2017 Nov; 11(11):1630-1645. PubMed ID: 28922552
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic and genomic features of high-grade pattern and their subclasses in lung adenocarcinoma.
Ahn B; Yoon S; Kim D; Chun SM; Lee G; Kim HR; Jin Jang S; Sang Hwang H
Lung Cancer; 2022 Aug; 170():176-184. PubMed ID: 35820357
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
[TBL] [Abstract][Full Text] [Related]
11. Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma.
Cheng WC; Chang CY; Lo CC; Hsieh CY; Kuo TT; Tseng GC; Wong SC; Chiang SF; Huang KC; Lai LC; Lu TP; Chao KSC; Sher YP
Theranostics; 2021; 11(8):3661-3675. PubMed ID: 33664854
[No Abstract] [Full Text] [Related]
12. Single-cell transcriptome analysis demonstrates inter-patient and intra-tumor heterogeneity in primary and metastatic lung adenocarcinoma.
Liu Y; Ye G; Huang L; Zhang C; Sheng Y; Wu B; Han L; Wu C; Dong B; Qi Y
Aging (Albany NY); 2020 Nov; 12(21):21559-21581. PubMed ID: 33170151
[TBL] [Abstract][Full Text] [Related]
13. RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway.
Zhang D; Jiang Q; Ge X; Shi Y; Ye T; Mi Y; Xie T; Li Q; Ye Q
Int J Biol Sci; 2021; 17(10):2622-2632. PubMed ID: 34326698
[TBL] [Abstract][Full Text] [Related]
14. Genomic landscape of metastatic lung adenocarcinomas from large-scale clinical sequencing.
Li D; Huang Y; Cai L; Wu M; Bao H; Xu Y; Wei Y; Wu S; Wu X; Shao Y; Zhao W; Lv G; Huang S; Zhang T; Shi Y
Neoplasia; 2021 Dec; 23(12):1204-1212. PubMed ID: 34735995
[TBL] [Abstract][Full Text] [Related]
15. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
Yang Y; Wang M; Liu B
J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
[TBL] [Abstract][Full Text] [Related]
16. An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2.
Cardnell RJ; Behrens C; Diao L; Fan Y; Tang X; Tong P; Minna JD; Mills GB; Heymach JV; Wistuba II; Wang J; Byers LA
Clin Cancer Res; 2015 Aug; 21(15):3480-91. PubMed ID: 25878335
[TBL] [Abstract][Full Text] [Related]
17. The Combination Of Weak Expression Of PRDX4 And Very High MIB-1 Labelling Index Independently Predicts Shorter Disease-free Survival In Stage I Lung Adenocarcinoma.
Shioya A; Guo X; Motono N; Mizuguchi S; Kurose N; Nakada S; Aikawa A; Ikeda Y; Uramoto H; Yamada S
Int J Med Sci; 2018; 15(10):1025-1034. PubMed ID: 30013444
[No Abstract] [Full Text] [Related]
18. The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma.
Caso R; Sanchez-Vega F; Tan KS; Mastrogiacomo B; Zhou J; Jones GD; Nguyen B; Schultz N; Connolly JG; Brandt WS; Bott MJ; Rocco G; Molena D; Isbell JM; Liu Y; Mayo MW; Adusumilli PS; Travis WD; Jones DR
J Thorac Oncol; 2020 Dec; 15(12):1844-1856. PubMed ID: 32791233
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of BUBs gene family in lung adenocarcinoma with immunological analysis.
Li X; Wang T; Li M; Bao X; Ma T; Yang C; Wu H; Li H
Aging (Albany NY); 2023 Feb; 15(3):810-829. PubMed ID: 36787437
[TBL] [Abstract][Full Text] [Related]
20. Nonnegative matrix factorization-based bioinformatics analysis reveals that TPX2 and SELENBP1 are two predictors of the inner sub-consensuses of lung adenocarcinoma.
Wang H; Wang X; Xu L; Cao H; Zhang J
Cancer Med; 2021 Dec; 10(24):9058-9077. PubMed ID: 34734491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
